In a phase I clinical trial funded by the National Institutes of Health and the Maryland Stem Cell Research Fund, Johns Hopkins Medicine ...

Highlight Therapeutics, a clinical‑stage biotechnology company developing immune activators to transform the treatment of skin tumors, today ...

A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a groundbreaking pathway-targeted therapy could ...

Bacteria are becoming increasingly resistant to antibiotics. One alternative is treatment with viruses that exclusively infect bacteria, known ...

By opening temporary microscopic channels in the skin, microneedle patches could help next-generation cosmetics deliver stronger results, from ...

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may ...